Literature DB >> 1775849

The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.

S M Levitz1.   

Abstract

The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis are reviewed. Two varieties of C. neoformans have been recognized. C. neoformans variety neoformans has been found in nature worldwide, primarily in association with bird droppings, although nonavian sources have also been found. Most cases of human cryptococcosis are caused by this variety. C. neoformans var. gattii has recently been isolated in nature in association with Eucalyptus trees. Infections caused by this variety occur mainly in tropical and subtropical regions. Because exposure to C. neoformans is probably common and clinically apparent cases of cryptococcosis in healthy hosts are rare, it is presumed that most people can mount adequate host defenses upon exposure to the organism. At least 5%-10% of patients with AIDS become infected with Cryptococcus; the epidemiology of this infection is different in many respects from that seen in patients without AIDS.

Entities:  

Mesh:

Year:  1991        PMID: 1775849     DOI: 10.1093/clinids/13.6.1163

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  107 in total

1.  Does amoeboid reasoning explain the evolution and maintenance of virulence factors in Cryptococcus neoformans?

Authors:  S M Levitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

3.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Cryptococcal Meningitis in HIV-Infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

5.  Challenges in dealing with a cirrhotic patient.

Authors:  Diana Spinelli; Sarah Damanti; Francesca Minonzio; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2012-03-15       Impact factor: 3.397

6.  Ferrous iron uptake in Cryptococcus neoformans.

Authors:  E S Jacobson; A P Goodner; K J Nyhus
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.

Authors:  M J Coffey; S M Phare; S George; M Peters-Golden; P H Kazanjian
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.

Authors:  A C N Delgado; H Taguchi; Y Mikami; M Myiajy; M C B Villares; M L Moretti
Journal:  Mycopathologia       Date:  2005-01       Impact factor: 2.574

10.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.